跳至主要内容
临床试验/NCT07077473
NCT07077473招募中不适用

A Retrospective Study Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases

Tongji Hospital2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2018年1月1日最近更新:
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
12
试验地点
2
主要终点
Clinical responses graded as Patient Global Assessment (PGA ) decrease

研究概览

简要总结

retrospective observe the efficacy and safety of different drugs used in familial Mediterranean fever (FMF) cases in real-world

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • - Clinical diagnosis of Familial Mediterranean fever (FMF) patients (Tel Hashomer criteria)

排除标准

  • Have a history of mental illness, or alcohol and drug dependence;
  • Pregnant, with severe infection, severe cardiac insufficiency, severe liver or kidney dysfunction;
  • Complicated with tumors, organ transplants, etc. which have significant impact on the immune system or require the use of immunosuppressants.

结局指标

主要结局

Clinical responses graded as Patient Global Assessment (PGA ) decrease

时间窗: From baseline,4, 8, 12, 24 and week 52

The treatment outcome was graded as PGA decrease:in-response, partial response, good response, or clinical remission corresponding to symptomatic improvement \<30%, 30% to 50%, 50% to 70%, or \>70%, respectively. PGA is a subjective measure where patients rate their overall disease activity or health status on a scale like a visual analog scale (VAS).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

YIKAI YU

Doctor

Tongji Hospital

研究点 (2)

Loading locations...

相似试验